Trexquant Investment LP Veru Inc. Transaction History

Trexquant Investment LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 11, 2022	SELL	$4.35 - $15.85 $127,189 - $463,438	-29,239 Reduced 64.66%	15,984 $181,000
Q1 2022 May 13, 2022	BUY	$4.55 - $6.41 $26,699 - $37,613	5,868 Added 14.91%	45,223 $218,000
Q4 2021 Feb 14, 2022	BUY	$5.89 - $9.73 $231,800 - $382,924	39,355 New	39,355 $232,000
Q3 2021 Nov 12, 2021	SELL	$6.78 - $9.89 $135,227 - $197,256	-19,945 Closed	0 $0
Q2 2021 Aug 12, 2021	BUY	$7.24 - $11.2 $144,401 - $223,384	19,945 New	19,945 $161,000

126

57.2M

668K

531K

Ticker VERU
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 80,146,704
Market Cap $41.7M
Description
Veru Inc., an oncology biopharmaceutical company, focuses on developing medicines for the management of cancers. Its commercial products comprise FC2 female condom/internal condom for the dual protection against unintended pregnancy and the transmission of sexually transmitted infections for ministries of health, government health agencies, U.N....

Get notified when there are updates to the investment portfolio of Trexquant Investment LP, based on Form 13F filings with the SEC.

Stay updated on Trexquant Investment LP with notifications on news.